Summary

The global vascular stent market is projected to expand to US$17.1 billion by 2032, increasing from US$14.2 billion in 2025, at a CAGR of 7.3% from 2025 to 2032. The market is driven by the rising prevalence of cardiovascular diseases, technological advancements in stent materials and designs, and a growing preference for minimally invasive procedures. Bio-absorbable stents are further shaping the market's future with their enhanced safety profiles.

Market Insights

• Drug-eluting stents (DES) are projected to account for over 55% of the market share by 2025 due to their superior ability to prevent restenosis.

• The rising prevalence of coronary artery disease (CAD) and atherosclerosis is fueling demand for vascular stents globally.

• Advances in bio-absorbable and hybrid-material stents are enhancing safety and treatment outcomes.

• North America leads the market due to its advanced healthcare sector, while Asia Pacific is the fastest-growing region driven by increased healthcare investments and disease incidence.

• Healthcare infrastructure development in Asia Pacific and Latin America offers lucrative market opportunities.

• The preference for minimally invasive procedures is driving vascular stent adoption worldwide.

• Biocompatibility and long-term safety remain key focus areas in stent innovation.

Market Drivers

1. Growing Adoption of Minimally Invasive Techniques

The vascular stent market is expanding due to the rising preference for minimally invasive surgical techniques. Angioplasty and related procedures offer benefits such as faster recovery, fewer postoperative complications, and smaller incisions. Over 1 million percutaneous coronary interventions (PCIs) are performed annually in the U.S., demonstrating the essential role of vascular stents in contemporary cardiovascular treatment.

2. Technological Innovations in Stents

Innovative developments in vascular stents are reshaping the market. Drug-eluting stents (DES), which release medication to minimize restenosis, have enhanced patient outcomes. Additionally, bio-absorbable stents, which dissolve naturally after completing their function, are reducing long-term complications. Advanced imaging systems, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), are also improving precision in stent placement, thereby lowering procedural risks.

Business Opportunities

1. Expansion of Bioresorbable Stents

Bio-absorbable vascular scaffold (BRS) stents are gaining momentum as they provide temporary structural support before dissolving, reducing the presence of foreign material in the body. As regulatory approvals rise and manufacturing costs decline, the adoption of bio-absorbable stents is expected to increase significantly.

2. Integration of AI and Robotics in Cardiology

The use of artificial intelligence (AI) and robotics in interventional cardiology is transforming stent procedures. AI-driven imaging enhances stent placement accuracy, while robotic-assisted surgeries improve precision and consistency, reducing complications. This technological evolution is driving demand for advanced vascular stents with enhanced functionalities.

Challenges Facing the Market

1. High Costs of Stent Procedures

The high expense of vascular stents and related procedures remains a key barrier, particularly in developing nations. Premium stents, such as drug-eluting and bio-absorbable stents, may be unaffordable for many patients without sufficient insurance coverage.

2. Regulatory Hurdles

Strict regulatory approval processes hinder the market entry of new stents. Compliance with different regional regulatory requirements presents additional challenges for manufacturers seeking to commercialize products worldwide.

Regional Market Overview

North America: Leading the Industry

North America continues to hold the largest market share due to a high prevalence of cardiovascular diseases, a well-developed healthcare system, and supportive reimbursement policies. Strong R&D investments and the presence of leading medical device manufacturers further strengthen the market.

Europe: A Significant Contributor

Europe ranks as the second-largest market, led by Germany, the UK, and France. Robust healthcare infrastructure, high disease awareness, and a preference for minimally invasive treatments contribute to market expansion. CE regulatory approvals ensure the availability of high-quality stent technologies in the region.

Asia Pacific: Rapid Market Expansion

Asia Pacific is the fastest-growing market, driven by increased healthcare spending, a rising incidence of cardiovascular diseases, and improved access to medical devices. Countries such as China, India, and Japan are experiencing heightened demand due to advancing healthcare systems and increasing patient awareness.

Latin America & Middle East and Africa: Emerging Growth Regions

These markets offer strong growth potential due to government initiatives to enhance healthcare accessibility, a growing burden of cardiovascular diseases, and rising healthcare expenditures.

Key Players in the Market

The vascular stent market remains highly competitive, with major players investing in innovation, partnerships, and acquisitions to expand their market share. Leading companies include:

• Medtronic

• Abbott Laboratories

• Cardiovascular Systems, Inc.

• Boston Scientific Corporation

• AngioDynamics

• Edwards Lifesciences Corporation

• Biosensors International Group, Ltd.

• W.L. Gore & Associates, Inc.

• Merit Medical Systems

Recent Market Developments

• May 2024: Abbott Laboratories introduced the XIENCE Sierra Everolimus Drug-Eluting Coronary Stent System in India, further expanding its advanced stent offerings.

• January 2023: BioMatrix™ Alpha launched a next-generation stent with an innovative pro-healing coating, improving safety and biocompatibility.

Market Segmentation

By Type:

• Drug-Eluting Stents (DES)

• Bare-Metal Stents

• Bio-absorbable Stents

By Material:

• Metal

• Polymeric

• Combination

By End User:

• Hospitals

• Ambulatory Surgery Centers (ASCs)

• Specialty Clinics

By Region:

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Vascular Stent Market Snapsshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Economic Overview
2.7. PESTLE Analysis
3. Price Analysis, 2025
3.1. Global Average Price Analysis, by Type, US$ Per Unit, 2025
3.2. Prominent Factor Affecting Vascular Stent Market Prices
3.3. Global Average Price Analysis, by Region, US$ Per Unit
4. Global Vascular Stent Market Outlook, 2019 - 2032
4.1. Global Vascular Stent Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
4.1.1. Key Highlights
4.1.1.1. Drug-Eluting Stents
4.1.1.2. Bare-Metal Stents
4.1.1.3. Bio absorbable Stents
4.1.1.4. Others
4.2. Global Vascular Stent Market Outlook, by Material, Value (US$ Bn) and Volume (Units), 2019 - 2032
4.2.1. Key Highlights
4.2.1.1. Metal
4.2.1.2. Polymeric
4.2.1.3. Combination
4.3. Global Vascular Stent Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019 - 2032
4.3.1. Key Highlights
4.3.1.1. Hospitals
4.3.1.2. Ambulatory Surgery Centers (ASCs)
4.3.1.3. Specialty Clinics
4.4. Global Vascular Stent Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2019 - 2032
4.4.1. Key Highlights
4.4.1.1. North America
4.4.1.2. Europe
4.4.1.3. Asia Pacific
4.4.1.4. Latin America
4.4.1.5. Middle East & Africa
5. North America Vascular Stent Market Outlook, 2019 - 2032
5.1. North America Vascular Stent Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
5.1.1. Key Highlights
5.1.1.1. Drug-Eluting Stents
5.1.1.2. Bare-Metal Stents
5.1.1.3. Bio absorbable Stents
5.1.1.4. Others
5.2. North America Vascular Stent Market Outlook, by Material, Value (US$ Bn) and Volume (Units), 2019 - 2032
5.2.1. Key Highlights
5.2.1.1. Metal
5.2.1.2. Polymeric
5.2.1.3. Combination
5.3. North America Vascular Stent Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019 - 2032
5.3.1. Key Highlights
5.3.1.1. Hospitals
5.3.1.2. Ambulatory Surgery Centers (ASCs)
5.3.1.3. Specialty Clinics
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. North America Vascular Stent Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
5.4.1. Key Highlights
5.4.1.1. U.S. Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
5.4.1.2. U.S. Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
5.4.1.3. U.S. Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
5.4.1.4. Canada Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
5.4.1.5. Canada Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
5.4.1.6. Canada Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Europe Vascular Stent Market Outlook, 2019 - 2032
6.1. Europe Vascular Stent Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
6.1.1. Key Highlights
6.1.1.1. Drug-Eluting Stents
6.1.1.2. Bare-Metal Stents
6.1.1.3. Bio absorbable Stents
6.1.1.4. Others
6.2. Europe Vascular Stent Market Outlook, by Material, Value (US$ Bn) and Volume (Units), 2019 - 2032
6.2.1. Key Highlights
6.2.1.1. Metal
6.2.1.2. Polymeric
6.2.1.3. Combination
6.3. Europe Vascular Stent Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019 - 2032
6.3.1. Key Highlights
6.3.1.1. Hospitals
6.3.1.2. Ambulatory Surgery Centers (ASCs)
6.3.1.3. Specialty Clinics
6.3.2. Attractiveness Analysis
6.4. Europe Vascular Stent Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
6.4.1. Key Highlights
6.4.1.1. Germany Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
6.4.1.2. Germany Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
6.4.1.3. Germany Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
6.4.1.4. U.K. Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
6.4.1.5. U.K. Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
6.4.1.6. U.K. Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
6.4.1.7. France Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
6.4.1.8. France Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
6.4.1.9. France Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
6.4.1.10. Italy Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
6.4.1.11. Italy Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
6.4.1.12. Italy Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
6.4.1.13. Turkey Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
6.4.1.14. Turkey Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
6.4.1.15. Turkey Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
6.4.1.16. Russia Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
6.4.1.17. Russia Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
6.4.1.18. Russia Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
6.4.1.19. Rest of Europe Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
6.4.1.20. Rest of Europe Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
6.4.1.21. Rest of Europe Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Asia Pacific Vascular Stent Market Outlook, 2019 - 2032
7.1. Asia Pacific Vascular Stent Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
7.1.1. Key Highlights
7.1.1.1. Drug-Eluting Stents
7.1.1.2. Bare-Metal Stents
7.1.1.3. Bio absorbable Stents
7.1.1.4. Others
7.2. Asia Pacific Vascular Stent Market Outlook, by Material, Value (US$ Bn) and Volume (Units), 2019 - 2032
7.2.1. Key Highlights
7.2.1.1. Metal
7.2.1.2. Polymeric
7.2.1.3. Combination
7.3. Asia Pacific Vascular Stent Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019 - 2032
7.3.1. Key Highlights
7.3.1.1. Hospitals
7.3.1.2. Ambulatory Surgery Centers (ASCs)
7.3.1.3. Specialty Clinics
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Asia Pacific Vascular Stent Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
7.4.1. Key Highlights
7.4.1.1. China Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
7.4.1.2. China Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
7.4.1.3. China Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
7.4.1.4. Japan Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
7.4.1.5. Japan Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
7.4.1.6. Japan Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
7.4.1.7. South Korea Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
7.4.1.8. South Korea Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
7.4.1.9. South Korea Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
7.4.1.10. India Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
7.4.1.11. India Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
7.4.1.12. India Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
7.4.1.13. Southeast Asia Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
7.4.1.14. Southeast Asia Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
7.4.1.15. Southeast Asia Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
7.4.1.16. Rest of Asia Pacific Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
7.4.1.17. Rest of Asia Pacific Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
7.4.1.18. Rest of Asia Pacific Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Latin America Vascular Stent Market Outlook, 2019 - 2032
8.1. Latin America Vascular Stent Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
8.1.1. Key Highlights
8.1.1.1. Drug-Eluting Stents
8.1.1.2. Bare-Metal Stents
8.1.1.3. Bio absorbable Stents
8.1.1.4. Others
8.2. Latin America Vascular Stent Market Outlook, by Material, Value (US$ Bn) and Volume (Units), 2019 - 2032
8.2.1. Key Highlights
8.2.1.1. Metal
8.2.1.2. Polymeric
8.2.1.3. Combination
8.3. Latin America Vascular Stent Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019 - 2032
8.3.1. Key Highlights
8.3.1.1. Hospitals
8.3.1.2. Ambulatory Surgery Centers (ASCs)
8.3.1.3. Specialty Clinics
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Latin America Vascular Stent Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
8.4.1. Key Highlights
8.4.1.1. Brazil Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
8.4.1.2. Brazil Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
8.4.1.3. Brazil Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
8.4.1.4. Mexico Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
8.4.1.5. Mexico Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
8.4.1.6. Mexico Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
8.4.1.7. Argentina Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
8.4.1.8. Argentina Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
8.4.1.9. Argentina Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
8.4.1.10. Rest of Latin America Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
8.4.1.11. Rest of Latin America Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
8.4.1.12. Rest of Latin America Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Middle East & Africa Vascular Stent Market Outlook, 2019 - 2032
9.1. Middle East & Africa Vascular Stent Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
9.1.1. Key Highlights
9.1.1.1. Drug-Eluting Stents
9.1.1.2. Bare-Metal Stents
9.1.1.3. Bio absorbable Stents
9.1.1.4. Others
9.2. Middle East & Africa Vascular Stent Market Outlook, by Material, Value (US$ Bn) and Volume (Units), 2019 - 2032
9.2.1. Key Highlights
9.2.1.1. Metal
9.2.1.2. Polymeric
9.2.1.3. Combination
9.3. Middle East & Africa Vascular Stent Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019 - 2032
9.3.1. Key Highlights
9.3.1.1. Hospitals
9.3.1.2. Ambulatory Surgery Centers (ASCs)
9.3.1.3. Specialty Clinics
9.3.2. BPS Analysis/Market Attractiveness Analysis
9.4. Middle East & Africa Vascular Stent Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
9.4.1. Key Highlights
9.4.1.1. GCC Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
9.4.1.2. GCC Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
9.4.1.3. GCC Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
9.4.1.4. South Africa Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
9.4.1.5. South Africa Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
9.4.1.6. South Africa Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
9.4.1.7. Egypt Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
9.4.1.8. Egypt Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
9.4.1.9. Egypt Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
9.4.1.10. Nigeria Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
9.4.1.11. Nigeria Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
9.4.1.12. Nigeria Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
9.4.1.13. Rest of Middle East & Africa Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
9.4.1.14. Rest of Middle East & Africa Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
9.4.1.15. Rest of the Middle East & Africa Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
9.4.2. BPS Analysis/Market Attractiveness Analysis
10. Competitive Landscape
10.1. Company Market Share Analysis, 2025
10.2. Competitive Dashboard
10.3. Company Profiles
10.3.1. Medtronic
10.3.1.1. Company Overview
10.3.1.2. Product Portfolio
10.3.1.3. Financial Overview
10.3.1.4. Business Strategies and Development
10.3.2. Abbott
10.3.2.1. Company Overview
10.3.2.2. Product Portfolio
10.3.2.3. Financial Overview
10.3.2.4. Business Strategies and Development
10.3.3. Cardiovascular Systems, Inc.
10.3.3.1. Company Overview
10.3.3.2. Product Portfolio
10.3.3.3. Financial Overview
10.3.3.4. Business Strategies and Development
10.3.4. Boston Scientific Corporation
10.3.4.1. Company Overview
10.3.4.2. Product Portfolio
10.3.4.3. Financial Overview
10.3.4.4. Business Strategies and Development
10.3.5. AngioDynamics
10.3.5.1. Company Overview
10.3.5.2. Product Portfolio
10.3.5.3. Financial Overview
10.3.5.4. Business Strategies and Development
10.3.6. Edwards Lifesciences Corporation
10.3.6.1. Company Overview
10.3.6.2. Product Portfolio
10.3.6.3. Financial Overview
10.3.6.4. Business Strategies and Development
10.3.7. Biosensors International Group, Ltd.
10.3.7.1. Company Overview
10.3.7.2. Product Portfolio
10.3.7.3. Financial Overview
10.3.7.4. Business Strategies and Development
10.3.8. W. L. Gore & Associates, Inc.
10.3.8.1. Company Overview
10.3.8.2. Product Portfolio
10.3.8.3. Financial Overview
10.3.8.4. Business Strategies and Development
10.3.9. Merit Medical Systems.
10.3.9.1. Company Overview
10.3.9.2. Product Portfolio
10.3.9.3. Financial Overview
10.3.9.4. Business Strategies and Development
10.3.10. Others
10.3.10.1. Company Overview
10.3.10.2. Product Portfolio
10.3.10.3. Financial Overview
10.3.10.4. Business Strategies and Development
11. Appendix
11.1. Research Methodology
11.2. Report Assumptions
11.3. Acronyms and Abbreviations